Skip to content

Author

Y. Uyanıkgil

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Research and Development Process, Regulatory Requirements and Clinical Trial of Medical Devices: A Review within the Framework of the Turkish Medicines and Medical Devices Agency (TITCK) and the European Union (Regulation 2017/745)

This review addresses the medical device lifecycle from a regulatory and scientific perspective, covering device definition and risk-based classification, the design and development process and the supporting quality and risk management standards, preclinical laboratory and biological evaluation, in vivo studies, and c...

Umut Doğu Seçkin, Aylin Buhur, Y. Uyanıkgil · 0 citations
Open access Aug 2026

Drug Repurposing of Verapamil for Radiation-Induced Enteropathy: Regulation of 5-LOX, Nrf2, and Intestinal Barrier Function

Investigating the protective effects of verapamil on radiation-induced small-intestinal injury in rats found it attenuated radiation-induced histopathological injury and was associated with favorable modulation of TNF-α, 5-LOX, Nrf2, and ZO-1 levels.

M. Daşıran, Hassen Daghmoura, A. Akbaş et al. · 0 citations
Open access Sep 2026

Intranasal Delivery of Solid Lipid Nanoparticles Loaded with Carmustine and Temozolomide for Glioblastoma Treatment in Mice

Intranasally administered solid lipid nanoparticles co-loaded with temozolomide and carmustine provide a promising nanoparticle-based strategy that offers a viable, low-toxicity alternative to improve clinical outcomes in aggressive brain tumors.

Ayşe Ünal, Güliz Ak, Habibe Yılmaz et al. · 0 citations
Sep 2026

Therapeutic Potential of Pioglitazone in a Propionic Acid-Induced Rat Model of Autism Spectrum Disorder: The Role of the SIRT1/PPAR-γ Axis.

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by social communication deficits and repetitive behaviours. Emerging evidence highlights neuroinflammation, oxidative stress and mitochondrial dysfunction in its pathogenesis. Propionic acid (PPA), an enteric short-chain fatty acid,...

A. Erdoğan, M. Erdoğan, Y. Uyanıkgil et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.